Folic acid-containing compound biosynthetic process

pathway activity — cross-omics
GO:0009396Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Folic acid-containing compound biosynthetic process pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are RIOX2, SETX_S2639, and PGAP4, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Folic acid-containing compound biosynthetic process activity versus RIOX2 in LSCC (Pearson r = 0.29).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCRIOX2 →+0.472+0.056<.001.00135
OVSETX_S2639 →+0.734+0.044.002.00934
LSCCPGAP4 →+0.940+0.102<.001<.00134
UCECMICAL2 →-0.382-0.072<.001<.00134
GBMCBR1 →+0.358+0.066<.001<.00134
OVBCAR3_S290 →-0.392-0.041.004<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009396 vs RIOX2 — LSCC

Per-sample scatter of Folic acid-containing compound biosynthetic process activity vs RIOX2 in LSCC.

Explore this scatter interactively →

Exploration